'Identifying spatial and temporal heterogeneity of cancer pathway activity in patient-derived GBM organoids
Bijdrage Stichting STOPhersentumoren.nl: 34.000,- euro per 2 november 2018
Towards Liquid biopsies to uncover Atypical/Malignant Meningioma and hemangiopericytomas
Bijdrage Stichting STOPhersentumoren.nl: 21.000,- euro per 16 november 2018
Development of an individualized drug-‐screening tool for guiding therapy selection in glioblastoma patients
Bijdrage Stichting STOPhersentumoren.nl: 86.082,- euro per 31 december 2018
International Low Grade Glioma Registry
Bijdrage Stichting STOPhersentumoren.nl: 15.000,- euro per 13 december 2018